BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21CIP1and p27KIP1

Biochemical and Biophysical Research Communications

Volumn 285, Issue 3, 2001, Pages 773-781

  Franzén, Åsa ^a   Heldin, Nils Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BMP 7; Density dependent; G1 arrest; P21; P27; PRb; Thyroid carcinoma.

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; OSTEOGENIC PROTEIN 1; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THYROID CARCINOMA;

EID: 0034810710     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5212     Document Type: Article

References (51)

1. Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches
2. Growth factors, thyroid hyperplasia, and neoplasia
3. Effects of transforming growth factor-beta on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture
4. General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture
5. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: Negative regulation of thyrocyte growth and function
6. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells
7. The family of bone morphogenetic proteins
8. Cloning and characterization of a human type II receptor for bone morphogenetic proteins
9. Characterization of type I receptors for transforming growth factor-beta and activin
10. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs
11. Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity
12. Intracellular signaling of osteogenic protein-1 through Smad5 activation
13. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2
14. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways
15. The Tlx-2 homeobox gene is a downstream target of BMP signalling and is required for mouse mesoderm development
16. Requirement for Xvent-1 and Xvent-2 gene function in dorsoventral patterning of Xenopus mesoderm
17. Induction of Smad6 mRNA by bone morphogenetic proteins
18. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation
19. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains
20. Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells
21. Involvement of p21(WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition
22. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta
23. Cyclins and cell cycle checkpoints
24. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation
25. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro
26. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation
27. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells
28. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
29. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest
30. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: Evidence for cooperation between p21Cip1/WAF1 and p27Kip1
31. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down-or up-regulation of p21/Waf1
32. P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
33. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
34. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
35. Formation and growth of multicellular spheroids of human origin
36. Coexpression of functionally active receptors for thyrotropin and platelet-derived growth factor in human thyroid carcinoma cells
37. Cytogenetical observations in five human anaplastic thyroid carcinomas
38. Fibrosis in undifferentiated (anaplastic) thyroid carcinomas: Evidence for a dual action of tumour cells in collagen type I synthesis
39. Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro
40. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
41. The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation
42. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases
43. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor
44. Evidence for the upregulation of osteogenic protein-1 mRNA expression in musculoskeletal neoplasms
45. Immunohistochemical evaluation of bone morphogenetic protein (BMP) in mixed tumor of skin
46. Expression of bone morphogenetic proteins of human neoplastic epithelial cells
47. Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7
48. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2
49. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix
50. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein
51. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells